Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(11%)
Results Posted
43%(3 trials)

Phase Distribution

Ph phase_1
1
11%
Ph phase_3
2
22%
Ph early_phase_1
1
11%
Ph phase_2
3
33%
Ph not_applicable
2
22%

Phase Distribution

2

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
3(33.3%)
Phase 3Large-scale testing
2(22.2%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(7)
Other(1)

Detailed Status

Completed7
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (11.1%)
Phase 11 (11.1%)
Phase 23 (33.3%)
Phase 32 (22.2%)
N/A2 (22.2%)

Trials by Status

unknown111%
recruiting111%
completed778%

Recent Activity

1 active trials
Showing 5 of 9
recruitingphase_3

Wisconsin Ginseng for Decreasing Cancer Related Fatigue

NCT06395441
completedearly_phase_1

Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors

NCT03407716
completedphase_2

American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL

NCT00752895
unknownnot_applicable

American Ginseng for the Prevention of Moderate-severe Fatigue in Breast Cancer Patients

NCT03730298
completedphase_2

American Ginseng to Improve HIV-Associated Fatigue: A Randomized, Placebo-Controlled, Parallel Design, Multiple-Dose Clinical Trial

NCT01500096
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT06395441Phase 3

Wisconsin Ginseng for Decreasing Cancer Related Fatigue

Recruiting
NCT03407716Early Phase 1

Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors

Completed
NCT00752895Phase 2

American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL

Completed
NCT03730298Not Applicable

American Ginseng for the Prevention of Moderate-severe Fatigue in Breast Cancer Patients

Unknown
NCT01500096Phase 2

American Ginseng to Improve HIV-Associated Fatigue: A Randomized, Placebo-Controlled, Parallel Design, Multiple-Dose Clinical Trial

Completed
NCT01136928Phase 1

Pharmacokinetic Interaction Study of Efavirenz and American Ginseng in Healthy Volunteers

Completed
NCT00182780Not Applicable

American Ginseng in Treating Patients With Cancer-Related Fatigue

Completed
NCT00719563Phase 3

American Ginseng in Treating Patients With Fatigue Caused by Cancer

Completed
NCT02806349Phase 2

Konjac-Glucomannan Fibre Blend and American Ginseng in Type 2 Diabetes

Completed

All 9 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
9